![](/img/cover-not-exists.png)
P577 Cost-effectiveness of episodic or maintenance infliximab versus standard treatment in an incidence cohort of Crohn's disease patients with 10-years follow-up
Odes, S., Greenberg, D., Vardi, H., Friger, M., Stockbrugger, R., Munkholm, P.Volume:
7
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1016/S1873-9946(13)60598-X
Date:
February, 2013
File:
PDF, 52 KB
english, 2013